Deep Brain Stimulation Systems Market Definition And Segments
A deep brain stimulation (DBS) system is a medical device that uses implanted electrodes to deliver electrical pulses to specific areas of the brain. It is used to regulate abnormal brain activity and improve symptoms associated with a variety of neurological conditions.
The main products of deep brain stimulation systems are single channel and dual channel systems. Single-channel brain stimulation systems are devices used to apply targeted electrical or magnetic stimulation to specific regions of the brain. They are used for various applications, including Parkinson's disease, essential tremor, obsessive compulsive disorder, epilepsy, dystonia, and others by several end-users, such as hospitals, ambulatory surgical centers, neurological clinics, and other end users.
The deep brain stimulation systems market covered in this report is segmented –
1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.28 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising desire for less invasive operations among the general public, increasing demand for minimally invasive surgery in developed countries, rising demand for minimally invasive surgical procedures, high prevalence of diseases such as parkinson’s disease and epilepsy, increasing prevalence of neurological disorders.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing growth in the geriatric population, rising prevalence of neurological disorders globally, growing aging population, increasing acceptance of neurostimulation therapies, rising healthcare infrastructure development. Major trends in the forecast period include technological advancements in deep brain stimulation devices, advancements in technology, focus on non-motor symptoms, miniaturization and advanced materials, wireless connectivity and remote monitoring, multimodal therapies.
Rising Prevalence Of Neurological Disorders Ignites Growth In The Deep Brain Stimulation Systems Market
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body's autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson's Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based federal agency, up to 5.8 million Americans suffered from Alzheimer's disease in 2020, and this population is expected to almost triple to 14 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.
Major companies operating in the deep brain stimulation systems market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation
Launch Of World's Smallest Rechargeable Deep Brain Stimulation Device With Remote Programming
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician's office.
Aster Medcity And Medtronic Join Forces To Expand Advanced DBS Program For Early-Onset Parkinson's Patients In India
In August 2022, Aster Medcity, an India-based quaternary care multispecialty hospital, partnered with Medtronic plc. This partnership increases the outreach of the program to all Parkinson's patients, especially those with relatively early-onset or young-onset Parkinson's. The partnership also aims to build a comprehensive and advanced DBS program for the treatment of Parkinson's disease and other movement disorders. Medtronic plc. is an India-based medical device company that offers a full line of deep brain stimulation technology, technical experience, and support.
North America was the largest region in the deep brain stimulation systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the deep brain stimulation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The deep brain stimulation systems market research report is one of a series of new reports from The Business Research Company that provides deep brain stimulation systems market statistics, including deep brain stimulation systems industry global market size, regional shares, competitors with an deep brain stimulation systems market share, detailed deep brain stimulation systems market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. This deep brain stimulation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.